Active Ingredients: Montelukast Sodium
Action: Selective Leukotrienes receptor antagonist
Indications:
- Indicated in the treatment of asthma as add-on therapy in those 6 months to 5 years old patients and older with mild to moderate persistent asthma who are inadequately controlled on inhaled corticosteroids and in whom “as-needed” short acting beta agonists provide inadequate clinical control of asthma,
- Indicated in the prophylaxis of asthma from 2 years of age and older in which the predominant component is exercise-induced bronchoconstriction.
- In those asthmatic patients in whom Lelipel 10mg is indicated in asthma, Lelipel 1mg can also provide symptomatic relief of seasonal allergic rhinitis.